Summary

KEY FINDINGS
The global western blotting market is expected to reach $1.99 billion by 2032, growing at a CAGR of 6.67% during the forecast period 2024-2032. The base year considered for the study is 2023, and the estimated period is between 2024 and 2032. The market study has also analyzed the impact of COVID-19 on the global western blotting market qualitatively as well as quantitatively.
Western blotting, or immunoblotting, is a lab technique used to detect specific proteins within tissue homogenates or extracts. The process involves separating proteins by size via gel electrophoresis, transferring them onto a membrane, and probing the membrane with antibodies that specifically bind to the target protein. This method enables researchers to identify and quantify proteins, offering insights into protein expression, size, and post-translational modifications in biological samples.
MARKET INSIGHTS
Key growth enablers of the global western blotting market:
• Rising incidence of HIV and LYME disease
o The growing prevalence of HIV and Lyme disease is a key factor driving the growth of the Western blotting market. According to the World Health Organization, the HIV epidemic has impacted 85.6 million people, leading to around 40.4 million deaths worldwide. Meanwhile, Lyme disease, a tick-borne infection, has affected over 14% of the global population, as evidenced by antibodies found in blood samples.
o Given these alarming statistics, the need for accurate and dependable diagnostic tools has significantly increased. Western blotting, known for its capability to detect specific antibodies linked to HIV and Lyme disease pathogens, plays a crucial role in disease diagnosis and monitoring. By providing precise infection identification, it supports early intervention, treatment optimization, and effective monitoring of disease progression.
o As the global impact of HIV and Lyme disease continues to rise, western blotting is becoming increasingly vital in healthcare and research. The demand for western blotting assays is projected to grow substantially, fueled by the urgent need for reliable diagnostic solutions to address these widespread infectious diseases.
• Expanding role in proteomics applications
• Diverse applications of the western blot test
Key growth restraining factors of the global western blotting market:
• High antibody costs
• Rise of alternative technologies
o The rise of alternative technologies presents a significant challenge to the global western blotting market. Techniques like mass spectrometry-based proteomics and microarray assays provide benefits such as greater throughput, multiplexing capabilities, and potentially lower costs compared to conventional western blotting.
o These innovations could reduce the demand for western blotting as researchers and clinicians shift towards more efficient workflows and streamlined approaches for protein analysis.
o Furthermore, staying relevant in the market and responding to the shift in technology preferences pose major challenges for western blotting manufacturers. They must adjust their strategies to navigate this changing landscape.
• Need for enhanced procedural efficiency for precision
Global Western Blotting Market | Top Market Trends
o Recent technological advancements have led to the creation of automated western blotting systems, which enhance workflow efficiency, minimize hands-on time, and improve reproducibility. These benefits are driving increased adoption of these instruments in research and clinical laboratories.
o Innovations like digital imaging systems, advanced antibody technologies, and data analysis software have enhanced the sensitivity, accuracy, and speed of western blotting. These improvements enable more precise protein detection and quantification, thereby driving market growth.
o With the rise of personalized medicine, the demand for precise protein analysis techniques, such as western blotting, is increasing. This method is essential for identifying biomarkers, understanding disease pathways, and customizing treatments for individual patients, driving the need for western blotting products and services in both research and clinical settings.
SEGMENTATION ANALYSIS
Market Segmentation – Product, End-User, and Application –
Market by Product:
• Consumables
o Reagents and Buffers
o Kits
o Other Consumables
• Instruments
o Gel Electrophoresis Instruments
o Blotting Systems
 Dry Blotting Systems
 Semi-Dry Blotting Systems
 Wet Blotting Systems
• Imagers
o Chemiluminescent Imagers
o Fluorescent Imagers
o Other Imagers
Market by End-User:
• Research Institutes
• Pharmaceutical & Biotechnology Companies
o Pharmaceutical and biotechnology companies are major users of western blotting products and services. They employ this technique at various stages of drug discovery, development, and production.
o Western blotting is essential for protein characterization, target validation, quality control of biopharmaceuticals, and evaluating the efficacy of drug candidates. As the emphasis on biologics and personalized medicine intensifies, the demand for western blotting in these industries is anticipated to increase.
• Diagnostic Centers
• Other End-Users
Market by Application:
• Biomedical & Biochemical Research
• Disease Diagnostics
• Agriculture
o Western blotting is utilized in agriculture, especially within plant science and crop research. Researchers apply this technique to examine protein expression patterns, identify plant pathogens, characterize genetically modified organisms (GMOs), and evaluate the effectiveness of agricultural biotechnologies.
o Additionally, western blotting contributes to enhancing crop yields, developing disease-resistant varieties, and ensuring the safety and quality of agricultural products.
• Other Applications
REGIONAL ANALYSIS
Geographical Study based on Four Major Regions:
• North America: The United States and Canada
o North America is home to major manufacturers such as Bio-Rad Laboratories, Thermo Fisher Scientific, and GE Healthcare, which drive innovation and provide a wide range of western blotting products to cater to various research needs.
o Additionally, the region benefits from significant research funding, especially in the life sciences, which further promotes the adoption of western blotting techniques.
o Moreover, with a strong emphasis on personalized medicine, western blotting's crucial role in identifying disease-related protein biomarkers aligns seamlessly with North America's leading position in advancing tailored therapies for individual patients.
• Europe: The United Kingdom, Germany, France, Italy, Spain, Poland, Sweden, and Rest of Europe
• Asia-Pacific: China, Japan, India, South Korea, Indonesia, Thailand, Vietnam, Australia & New Zealand, and Rest of Asia-Pacific
• Rest of World: Latin America, the Middle East & Africa
COMPETITIVE INSIGHTS
Major players in the global western blotting market:
• Bio-Rad Laboratories
• Cell Signaling Technology
• Merck KGaA
• Thermo Fisher Scientific
• Roche Diagnostics
• GE Healthcare
Key strategies adopted by some of these companies:
• Azure Biosystems Inc introduced the chemiSOLO, a compact and cost-effective chemiluminescent imaging system, improving access to high-performance personal imaging solutions in January 2023.
• Bio-Techne and Cell Signaling Technology Inc launched simple western validation for CST antibodies in February 2023, streamlining molecular signaling pathway studies for researchers in various fields.
We Offer 10% Free Customization and 3 Months Analyst Support
Frequently Asked Questions (FAQs):
• Who are the key players in the global western blotting market?
A: Some of the key players in the global western blotting market include Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, and GE Healthcare.
• Are there any considerations for choosing the appropriate antibody in western blotting?
A: Choosing the appropriate antibody is essential for successful western blotting. Key considerations include the antibody's specificity, sensitivity, affinity, and compatibility with the target protein and detection method. It's also advisable to validate antibodies using positive and negative controls to guarantee accurate and dependable results.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. RISING POPULARITY OF DIGITAL WESTERN BLOTTING
2.5.2. INCREASING GOVERNMENT FUNDING IN BIOMEDICAL RESEARCH
2.5.3. GROWTH IN R&D INVESTMENT BY PHARMA AND BIOTECH COMPANIES
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. RISING INCIDENCE OF HIV AND LYME DISEASE
3.1.2. EXPANDING ROLE IN PROTEOMICS APPLICATIONS
3.1.3. DIVERSE APPLICATIONS OF THE WESTERN BLOT TEST
3.2. KEY RESTRAINTS
3.2.1. HIGH ANTIBODY COSTS
3.2.2. RISE OF ALTERNATIVE TECHNOLOGIES
3.2.3. NEED FOR ENHANCED PROCEDURAL EFFICIENCY FOR PRECISION
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.1.1. AUTOMATION OF WESTERN BLOT INSTRUMENTS
4.1.2. ADVANCEMENTS IN TECHNOLOGY
4.1.3. INCREASING DEMAND FOR PERSONALIZED MEDICINE
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
4.3.2. GROWTH PROSPECT MAPPING FOR UNITED KINGDOM
4.3.3. GROWTH PROSPECT MAPPING FOR INDIA
4.3.4. GROWTH PROSPECT MAPPING FOR MEXICO
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
5. MARKET BY PRODUCT
5.1. CONSUMABLES
5.1.1. REAGENTS AND BUFFERS
5.1.2. KITS
5.1.3. OTHER CONSUMABLES
5.2. INSTRUMENTS
5.2.1. GEL ELECTROPHORESIS INSTRUMENTS
5.2.2. BLOTTING SYSTEMS
5.2.2.1. DRY BLOTTING SYSTEMS
5.2.2.2. SEMI-DRY BLOTTING SYSTEMS
5.2.2.3. WET BLOTTING SYSTEMS
5.3. IMAGERS
5.3.1. CHEMILUMINESCENT IMAGERS
5.3.2. FLUORESCENT IMAGERS
5.3.3. OTHER IMAGERS
6. MARKET BY END-USER
6.1. RESEARCH INSTITUTES
6.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
6.3. DIAGNOSTIC CENTERS
6.4. OTHER END-USERS
7. MARKET BY APPLICATION
7.1. BIOMEDICAL & BIOCHEMICAL RESEARCH
7.2. DISEASE DIAGNOSTICS
7.3. AGRICULTURE
7.4. OTHER APPLICATIONS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. NORTH AMERICA WESTERN BLOTTING MARKET DRIVERS
8.1.3. NORTH AMERICA WESTERN BLOTTING MARKET CHALLENGES
8.1.4. KEY PLAYERS IN NORTH AMERICA WESTERN BLOTTING MARKET
8.1.5. COUNTRY ANALYSIS
8.1.5.1. UNITED STATES
8.1.5.1.1. UNITED STATES WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.1.5.2. CANADA
8.1.5.2.1. CANADA WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.2. EUROPE
8.2.1. MARKET SIZE & ESTIMATES
8.2.2. EUROPE WESTERN BLOTTING MARKET DRIVERS
8.2.3. EUROPE WESTERN BLOTTING MARKET CHALLENGES
8.2.4. KEY PLAYERS IN EUROPE WESTERN BLOTTING MARKET
8.2.5. COUNTRY ANALYSIS
8.2.5.1. UNITED KINGDOM
8.2.5.1.1. UNITED KINGDOM WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.2.5.2. GERMANY
8.2.5.2.1. GERMANY WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.2.5.3. FRANCE
8.2.5.3.1. FRANCE WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.2.5.4. ITALY
8.2.5.4.1. ITALY WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.2.5.5. SPAIN
8.2.5.5.1. SPAIN WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.2.5.6. POLAND
8.2.5.6.1. POLAND WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.2.5.7. SWEDEN
8.2.5.7.1. SWEDEN WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.2.5.8. REST OF EUROPE
8.2.5.8.1. REST OF EUROPE WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.3. ASIA-PACIFIC
8.3.1. MARKET SIZE & ESTIMATES
8.3.2. ASIA-PACIFIC WESTERN BLOTTING MARKET DRIVERS
8.3.3. ASIA-PACIFIC WESTERN BLOTTING MARKET CHALLENGES
8.3.4. KEY PLAYERS IN ASIA-PACIFIC WESTERN BLOTTING MARKET
8.3.5. COUNTRY ANALYSIS
8.3.5.1. CHINA
8.3.5.1.1. CHINA WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.3.5.2. JAPAN
8.3.5.2.1. JAPAN WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.3.5.3. INDIA
8.3.5.3.1. INDIA WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.3.5.4. SOUTH KOREA
8.3.5.4.1. SOUTH KOREA WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.3.5.5. INDONESIA
8.3.5.5.1. INDONESIA WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.3.5.6. THAILAND
8.3.5.6.1. THAILAND WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.3.5.7. VIETNAM
8.3.5.7.1. VIETNAM WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.3.5.8. AUSTRALIA & NEW ZEALAND
8.3.5.8.1. AUSTRALIA & NEW ZEALAND WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.3.5.9. REST OF ASIA-PACIFIC
8.3.5.9.1. REST OF ASIA-PACIFIC WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.4. REST OF WORLD
8.4.1. MARKET SIZE & ESTIMATES
8.4.2. REST OF WORLD WESTERN BLOTTING MARKET DRIVERS
8.4.3. REST OF WORLD WESTERN BLOTTING MARKET CHALLENGES
8.4.4. KEY PLAYERS IN REST OF WORLD WESTERN BLOTTING MARKET
8.4.5. REGIONAL ANALYSIS
8.4.5.1. LATIN AMERICA
8.4.5.1.1. LATIN AMERICA WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
8.4.5.2. MIDDLE EAST & AFRICA
8.4.5.2.1. MIDDLE EAST & AFRICA WESTERN BLOTTING MARKET SIZE & OPPORTUNITIES
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PARTNERSHIPS & AGREEMENTS
9.1.3. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ABCAM PLC
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. PRODUCTS
9.2.1.3. STRENGTHS & CHALLENGES
9.2.2. ADVANSTA
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCTS
9.2.2.3. STRENGTHS & CHALLENGES
9.2.3. AZURE BIOSYSTEMS INC
9.2.3.1. COMPANY OVERVIEW
9.2.3.2. PRODUCTS
9.2.3.3. STRENGTHS & CHALLENGES
9.2.4. BIO-RAD TECHNOLOGIES INC
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCTS
9.2.4.3. STRENGTHS & CHALLENGES
9.2.5. BIO-TECHNE CORPORATION
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. PRODUCTS
9.2.5.3. STRENGTHS & CHALLENGES
9.2.6. BOSTER BIOLOGICAL TECHNOLOGY
9.2.6.1. COMPANY OVERVIEW
9.2.6.2. PRODUCTS
9.2.6.3. STRENGTHS & CHALLENGES
9.2.7. CELL SIGNALING TECHNOLOGY INC
9.2.7.1. COMPANY OVERVIEW
9.2.7.2. PRODUCTS
9.2.7.3. STRENGTHS & CHALLENGES
9.2.8. ENZO BIOCHEM INC
9.2.8.1. COMPANY OVERVIEW
9.2.8.2. PRODUCTS
9.2.8.3. STRENGTHS & CHALLENGES
9.2.9. GENO TECHNOLOGY INC
9.2.9.1. COMPANY OVERVIEW
9.2.9.2. PRODUCTS
9.2.9.3. STRENGTHS & CHALLENGES
9.2.10. LI-COR BIOTECH LLC
9.2.10.1. COMPANY OVERVIEW
9.2.10.2. PRODUCTS
9.2.10.3. STRENGTHS & CHALLENGES
9.2.11. LUMIGEN INC
9.2.11.1. COMPANY OVERVIEW
9.2.11.2. PRODUCTS
9.2.11.3. STRENGTHS & CHALLENGES
9.2.12. MERCK KGAA
9.2.12.1. COMPANY OVERVIEW
9.2.12.2. PRODUCTS
9.2.12.3. STRENGTHS & CHALLENGES
9.2.13. PERKINELEMER INC
9.2.13.1. COMPANY OVERVIEW
9.2.13.2. PRODUCTS
9.2.13.3. STRENGTHS & CHALLENGES
9.2.14. ROCKLAND IMMUNOCHEMICALS INC
9.2.14.1. COMPANY OVERVIEW
9.2.14.2. PRODUCTS
9.2.14.3. STRENGTHS & CHALLENGES
9.2.15. STRESSMARQ BIOSCIENCES INC
9.2.15.1. COMPANY OVERVIEW
9.2.15.2. PRODUCTS
9.2.15.3. STRENGTHS & CHALLENGES
9.2.16. THERMO FISHER SCIENTIFIC LTD
9.2.16.1. COMPANY OVERVIEW
9.2.16.2. PRODUCTS
9.2.16.3. STRENGTHS & CHALLENGES